Search research articles
Contact Us
Filters
Showing results (201-210 of 228) with videos related to
Page
of 23
Sort By:
Cancer Cell
|
September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels
Wing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Investigational New Drugs
|
June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors
Khanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
BJU International
|
November 20, 2014
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
Fatima H Karzai, Andrea B Apolo, Liang Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2013
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis
Soichiro Yoshida, Shinji Tsutsumi, Guillaume Muhlebach, et al.
Nature Communications
|
March 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study
Junya Tabata, Tzu-Ting Huang, Elena Giudice, et al.
Cancer Research
|
May 17, 2018
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
Michael A Moses, Yeong Sang Kim, Genesis M Rivera-Marquez, et al.
Molecular Cell
|
February 18, 2010
Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function
Mehdi Mollapour, Shinji Tsutsumi, Alison C Donnelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2020
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
Matthew D Hellmann, Pasi A Jänne, Mateusz Opyrchal, et al.
Journal of Ethnopharmacology
|
July 16, 2021
Anti-inflammatory effect of Ailanthus altissima (Mill.) Swingle leaves in lipopolysaccharide-stimulated astrocytes
Sung Rae Kim, Yongun Park, Mo Li, et al.
Cancer Research and Treatment
|
September 4, 2020
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer
Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 228) with videos related to
Sort By:
Page
of 23
Cancer Cell
|
September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels
Wing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Investigational New Drugs
|
June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors
Khanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
BJU International
|
November 20, 2014
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
Fatima H Karzai, Andrea B Apolo, Liang Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2013
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis
Soichiro Yoshida, Shinji Tsutsumi, Guillaume Muhlebach, et al.
Nature Communications
|
March 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study
Junya Tabata, Tzu-Ting Huang, Elena Giudice, et al.
Cancer Research
|
May 17, 2018
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
Michael A Moses, Yeong Sang Kim, Genesis M Rivera-Marquez, et al.
Molecular Cell
|
February 18, 2010
Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function
Mehdi Mollapour, Shinji Tsutsumi, Alison C Donnelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2020
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
Matthew D Hellmann, Pasi A Jänne, Mateusz Opyrchal, et al.
Journal of Ethnopharmacology
|
July 16, 2021
Anti-inflammatory effect of Ailanthus altissima (Mill.) Swingle leaves in lipopolysaccharide-stimulated astrocytes
Sung Rae Kim, Yongun Park, Mo Li, et al.
Cancer Research and Treatment
|
September 4, 2020
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer
Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, et al.
Page
of 23